Does size matter for resection of giant versus non-giant hepatocellular carcinoma? A meta-analysis

Research on long-term survival after resection of giant (≥ 10 cm) and non-giant hepatocellular carcinoma (HCC) (< 10 cm) has produced conflicting results. This study aimed to investigate whether oncological outcomes and safety profiles of resection differ between giant and non-giant HCC. PubMed,...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastrointestinal surgery Vol. 15; no. 2; pp. 273 - 286
Main Authors: Lee, Aaron Jl, Wu, Andrew Gr, Yew, Kuo Chao, Shelat, Vishal G
Format: Journal Article
Language:English
Published: United States Baishideng Publishing Group Inc 27-02-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Research on long-term survival after resection of giant (≥ 10 cm) and non-giant hepatocellular carcinoma (HCC) (< 10 cm) has produced conflicting results. This study aimed to investigate whether oncological outcomes and safety profiles of resection differ between giant and non-giant HCC. PubMed, MEDLINE, EMBASE, and Cochrane databases were searched. Studies designed to investigate the outcomes of giant non-giant HCC were included. The primary endpoints were overall survival (OS) and disease-free survival (DFS). The secondary endpoints were postoperative complications and mortality rates. All studies were assessed for bias using the Newcastle-Ottawa Scale. 24 retrospective cohort studies involving 23747 patients (giant = 3326; non-giant = 20421) who underwent HCC resection were included. OS was reported in 24 studies, DFS in 17 studies, 30-d mortality rate in 18 studies, postoperative complications in 15 studies, and post-hepatectomy liver failure (PHLF) in six studies. The HR was significantly lower for non-giant HCC in both OS (HR 0.53, 95%CI: 0.50-0.55, < 0.001) and DFS (HR 0.62, 95%CI: 0.58-0.84, < 0.001). No significant difference was found for 30-d mortality rate (OR 0.73, 95%CI: 0.50-1.08, = 0.116), postoperative complications (OR 0.81, 95%CI: 0.62-1.06, = 0.140), and PHLF (OR 0.81, 95%CI: 0.62-1.06, = 0.140). Resection of giant HCC is associated with poorer long-term outcomes. The safety profile of resection was similar in both groups; however, this may have been confounded by reporting bias. HCC staging systems should account for the size differences.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author: Aaron JL Lee, MBBS, Doctor, Lee Kong Chian School of Medicine, Nanyang Technological University, No. 11 Mandalay Rd, Singapore 308232, Singapore. alee047@e.ntu.edu.sg
Author contributions: Lee AJ, Wu AG, Yew KC, Shelat VG confirm contribution to study conception and design; Lee AJ, Wu AG contributed to data collection; Lee AJ, Wu AG contributed to analysis and interpretation of results; Lee AJ, Wu AG, Yew KC, Shelat VG contributed to draft manuscript preparation; All authors reviewed the results and approved the final version of the manuscript
ISSN:1948-9366
1948-9366
DOI:10.4240/wjgs.v15.i2.273